NL192325B - Waterig, nasaal farmaceutisch preparaat dat dehydroergotamine bevat en sproeitoedieningsinrichting. - Google Patents

Waterig, nasaal farmaceutisch preparaat dat dehydroergotamine bevat en sproeitoedieningsinrichting.

Info

Publication number
NL192325B
NL192325B NL8300325A NL8300325A NL192325B NL 192325 B NL192325 B NL 192325B NL 8300325 A NL8300325 A NL 8300325A NL 8300325 A NL8300325 A NL 8300325A NL 192325 B NL192325 B NL 192325B
Authority
NL
Netherlands
Prior art keywords
dehydroergotamine
pharmaceutical composition
composition containing
delivery device
spray delivery
Prior art date
Application number
NL8300325A
Other languages
English (en)
Other versions
NL8300325A (nl
NL192325C (nl
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8300325A publication Critical patent/NL8300325A/nl
Publication of NL192325B publication Critical patent/NL192325B/nl
Application granted granted Critical
Publication of NL192325C publication Critical patent/NL192325C/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL8300325A 1982-02-01 1983-01-28 Waterig, nasaal farmaceutisch preparaat dat dehydroergotamine bevat en sproeitoedieningsinrichting. NL192325C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01
GB8202781 1982-02-01

Publications (3)

Publication Number Publication Date
NL8300325A NL8300325A (nl) 1983-09-01
NL192325B true NL192325B (nl) 1997-02-03
NL192325C NL192325C (nl) 1997-06-04

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8300325A NL192325C (nl) 1982-02-01 1983-01-28 Waterig, nasaal farmaceutisch preparaat dat dehydroergotamine bevat en sproeitoedieningsinrichting.

Country Status (27)

Country Link
JP (1) JPS58134017A (nl)
AT (1) AT385656B (nl)
AU (1) AU565613B2 (nl)
BE (1) BE895750A (nl)
CA (1) CA1197783A (nl)
CH (1) CH653555A5 (nl)
DE (1) DE3302949A1 (nl)
DK (1) DK164771C (nl)
ES (1) ES519450A0 (nl)
FI (1) FI81258C (nl)
FR (1) FR2539994B1 (nl)
GR (1) GR81320B (nl)
HK (1) HK59989A (nl)
HU (1) HU191512B (nl)
IE (1) IE54532B1 (nl)
IL (1) IL67822A (nl)
IT (1) IT1197558B (nl)
KE (1) KE3888A (nl)
LU (1) LU84613A1 (nl)
MY (1) MY8700766A (nl)
NL (1) NL192325C (nl)
NZ (1) NZ203117A (nl)
PH (1) PH22198A (nl)
PT (1) PT76166B (nl)
SE (1) SE454402B (nl)
SG (1) SG34389G (nl)
ZA (1) ZA83673B (nl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
KR20200118032A (ko) * 2018-01-05 2020-10-14 임펠 뉴로파마 인코포레이티드 정밀 후각기관 장치에 의한 디하이드로에르고타민의 비강내 전달

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
PT76166B (en) 1986-02-04
ZA83673B (en) 1984-09-26
ES8502865A1 (es) 1985-02-01
DK164771B (da) 1992-08-17
JPH0253406B2 (nl) 1990-11-16
NL8300325A (nl) 1983-09-01
ES519450A0 (es) 1985-02-01
SE454402B (sv) 1988-05-02
BE895750A (fr) 1983-08-01
PT76166A (en) 1983-02-01
ATA30383A (de) 1987-10-15
FI81258B (fi) 1990-06-29
DK38183A (da) 1983-08-02
IL67822A (en) 1988-02-29
IL67822A0 (en) 1983-06-15
FR2539994B1 (fr) 1986-10-10
AT385656B (de) 1988-05-10
GR81320B (nl) 1984-12-11
AU1085083A (en) 1983-08-11
CA1197783A (en) 1985-12-10
IE54532B1 (en) 1989-11-08
LU84613A1 (fr) 1983-09-08
MY8700766A (en) 1987-12-31
IE830187L (en) 1983-08-01
SE8300495L (sv) 1983-08-02
DE3302949A1 (de) 1983-08-11
FI830245L (fi) 1983-08-02
NZ203117A (en) 1986-12-05
HK59989A (en) 1989-08-04
FI830245A0 (fi) 1983-01-25
DE3302949C2 (nl) 1992-05-21
DK164771C (da) 1992-12-28
SE8300495D0 (sv) 1983-01-31
CH653555A5 (de) 1986-01-15
PH22198A (en) 1988-06-28
HU191512B (en) 1987-02-27
FR2539994A1 (fr) 1984-08-03
IT8347646A0 (it) 1983-02-01
IT1197558B (it) 1988-12-06
SG34389G (en) 1989-09-22
FI81258C (fi) 1990-10-10
KE3888A (en) 1989-09-01
AU565613B2 (en) 1987-09-24
JPS58134017A (ja) 1983-08-10
NL192325C (nl) 1997-06-04
DK38183D0 (da) 1983-01-31

Similar Documents

Publication Publication Date Title
MX9203263A (es) Composicion farmaceutica analgesica para administracion nasal.
NO822371L (no) Doseinhalator.
NO851881L (no) Innretning for avgivelse av flyktige, virksomme materialer.
DE69105609D1 (de) Verpackung für Mikrodosen von pulverförmigen Medikamenten zum Inhalieren.
IT8667329A0 (it) Dispositivo osmotico comprendente mezzi per regolare la durata iniziale di erogazione di un agente medicinale da detto dispositivo
GB2100605B (en) Bandage for administering drugs.
IT8548421A0 (it) Dispositivo distributore di tipo aerosol,in particolare per medicinali
DE3875025D1 (de) Calcitonin enthaltende zusammensetzung fuer die nasale verabreichung.
PH16812A (en) Amino acid derivatives,agent containing these compounds,and the use thereof
PT88404A (pt) Dosage form comprising fast agent delivery followed by slow agent delivery
IT8821065A0 (it) Dispositivo per l'inalazione di aerosol dosati.
ZA917528B (en) Nasal pharmaceutical composition.
NO152644C (no) Utleveringsinnretning for pastaformede produkter.
NO803685L (no) Medisindispenser (inhalator).
IT7923092V0 (it) Contenitore per due tipi di unita'di dosaggio in particolare per il trattamento delle vie respiratorie.
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
IT1209380B (it) Spruzzatore per sostanze in polvere.
NL190237C (nl) Amino-ethers en geneesmiddel dat deze amino-ethers bevat.
NO162056C (no) Innretning for medisinavlevering.
NO153129C (no) Utleveringsventil og -tutenhet.
BE894175A (fr) Nouvelles imidazotetrazinones, leur preparation et les medicaments qui les contiennent.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
NL194300B (nl) Farmaceutisch preparaat, dat een polyprenol als werkzaam bestanddeel bevat, alsmede voor toepassing daarin geschikte polyprenolen.
NL191307C (nl) Analgetisch werkzame piperazinederivaten en farmaceutische preparaten, die deze derivaten bevatten.
DE3581704D1 (de) Medikamentenabgabesystem.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
SNR Assignments of patents or rights arising from examined patent applications

Owner name: NOVARTIS AG

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20030128